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Summary
Hygromycin A, an antibiotic produced by Streptomy-
ces hygroscopicus NRRL 2388, offers a distinct car-
bon skeleton structure for development of antibacte-
rial agents targeting the bacterial ribosomal peptidyl
transferase. A 31.5 kb genomic DNA region covering
the hygromycin A biosynthetic gene cluster has been
identified, cloned, and sequenced. The hygromycin
gene cluster has 29 ORFs which can be assigned to
hygromycin A resistance as well as regulation and
biosynthesis of the three key moieties of hygromycin
A (5-dehydro-a-L-fucofuranose, (E)-3-(3,4-dihydroxy-
phenyl)-2-methylacrylic acid, and 2L-2-amino-2-deoxy-
4,5-O-methylene-neo-inositol. The predicted Hyg26
protein has sequence homology to short-chain alco-
hol dehydrogenases and is assigned to the final step
in production of the 5-dehydro-a-L-fucofuranose, cat-
alyzing the reduction of a-L-fucofuranose. A hyg26
mutant strain was generated and shown to produce
no hygromycin A but 500-dihydrohygromycin A, 500-di-
hydromethoxyhygromycin A, and a 500-dihydrohygro-
mycin A product lacking the aminocyclitol moiety. To
the best of our knowledge, these shunt metabolites
of biosynthetic pathway intermediates have not previ-
ously been identified. They provide insight into the
ordering of the multiple unusual steps which com-
promise the convergent hygromycin A biosynthetic
pathway.
Introduction
Hygromycin A (compound 1) (Figure 1) is an antibiotic
first isolated from the fermentation broth of several
strains of Streptomyces hygroscopicus in 1953 [1]. A
second structurally unrelated antibiotic, the aminogly-
coside hygromycin B, was later isolated from S. hygro-
scopicus [2]. Early studies demonstrated that hygromy-
cin A had a relatively broad spectrum of activity against
gram-positive and -negative bacteria [1, 3]. Almost three
decades later, Guerrero and Modolell demonstrated that
the mode of action was inhibition of the ribosomal pep-
tidyl transferase activity. Initial studies also demon-
strated that hygromycin A (1) blocked the binding of ei-
ther chloramphenicol or lincomycin to the ribosomes [4]
and (2) bound more tightly than chloramphenical. More
*Correspondence: reynoldsk@pdx.edurecent footprinting experiments have shown that macro-
lides only block binding of hygromycin A to the ribosome
if they contain a mycarose unit [5]. Crystallographic ev-
idence indicates that in such macrolides, the C5-disac-
charide group extends from the polypeptide exit chan-
nel into peptidyl transferase center [6]. Hygromycin A
is not a macrolide and thus offers a distinct carbon skel-
eton and binding mode to other antibiotics that target
the bacterial ribosome. As such, it represents a promis-
ing starting point for generating new antibiotics to treat
infections with drug-resistant pathogens.
Hygromycin A has also been reported to have addi-
tional activities and potential applications. It exhibits
hemagglutination inactivation activity and high antitre-
ponemal activity [7, 8], leading to the possible applica-
tion of hygromycin A-related compounds for the treat-
ment of swine dysentery, a severe mucohemorrhagic
disease thought to be caused by Serpulina (Treponema)
hyodysenteriae [8, 9]. Hygromycin A has also been re-
ported to possess an immunosuppressant activity in
the mixed poor lymphocyte reaction but does not work
via suppression of interleukin 2 production [10]. Most re-
cently, methoxyhygromycin A (compound 2) (Figure 1),
an analog of hygromycin A produced in the same fer-
mentation broth, has been shown to have herbicidal ac-
tivity and has led to the suggestion that it could be de-
veloped as a biological agent for weed control [11].
Semisynthetic programs based on hygromycin A and
its attractive biological properties have been reported
[12–14]. This work has led to the synthesis of over 100
analogs and determination of their activity, both in terms
of MICs for Serpulina hyodysenteriae and their ability to
inhibit protein synthesis in an E. coli cell extract. The re-
sulting structure activity relationship (SAR) has revealed
that the unusual aminocyclitol moiety is an important
component for the antibacterial activity, while the 5-de-
hydro-a-L-fucofuranose moiety is not essential and can
be replaced with hydrophobic allyl group. Reduction in
the antibacterial activity is also observed with replace-
ment in methyl group of central (E)-3-(3,4-dihydroxy-
phenyl)-2-methylacrylic acid moiety with propyl, allyl,
or hygrogen [14, 15]. For the most part, these structural
analogs were prepared by a semisynthetic method with
hygromycin A as a starting point. A total synthesis of hy-
gromycin A and C200epi-hygromycin A has also been re-
ported [12, 16]. Several multistep syntheses of the 2L-
2-amino-2-deoxy-4,5-O-methylene-neo-inositol moiety
have also been reported [17]. The most recent synthesis
of this was enantioselective and accomplished in 14
steps with an overall 12% yield [18].
We have sought a complementary approach of deci-
phering the biosynthetic process with a long-term aim
of using this as an economical means for generating hy-
gromycin analogs for further development. In our pre-
liminary work, we determined the biosynthetic origins
of the three unusual and structurally distinct moieties
of hygromycin A. Mannose was shown to provide the
5-dehydro-a-L-fucofuranose moiety, 4-hydroxybenzoic
acid and propionic acid the central (E)-3-(3,4-dihydroxy-
phenyl)-2-methylacrylic acid moiety, and glucose and
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754Figure 1. Structures of Hygromycin A, Hy-
gromycin A Analogs, and Related Com-
poundsmethionine the 2L-2-amino-2-deoxy-4,5-O-methylene-
neo-inositol moiety [19]. A convergent biosynthetic
pathway was proposed (Figure 2) from these observa-
tions, and we now report how this formed the basis for
a PCR approach that has led to the identification of the
hygromycin A biosynthetic gene cluster of S. hygroscipi-
cus NRRL 2388. The gene cluster has been cloned, se-
quenced, and analyzed, and putative assignments for
the majority of corresponding gene products in the bio-
synthesis of the three structural moieties of hygromycin
A have been proposed. Furthermore, manipulation of
the gene cluster has been shown to give rise to hygrom-
ycin A analogs and shunt products that have not previ-
ously been identified. These findings provide important
insights into the order of the biosynthetic steps andare a promising step toward the long-term objective of
this work.
Results and Discussion
Cloning and Sequencing of the Hygromycin A
Biosynthetic Gene Cluster
Previous studies on hygromycin A have suggested a
convergent biosynthesis from 5-dehydro-a-L-fucofura-
nose, (E)-3-(3,4-dihydroxyphenyl)-2-methylacrylic acid,
and 2L-2-amino-2-deoxy-4,5-O-methylene-neo-inositol
[19]. The 5-dehydro-a-L-fucofuranose moiety was
shown to be derived from mannose, and a pathway pro-
ceeding from a nucleoside diphosphate (NDP) activated
mannose, through NDP-4-keto-6-deoxymannose andFigure 2. Proposed Role of hyg Gene Prod-
ucts in Hygromycin A Biosynthesis in S.
hygroscopicus NRRL 2388
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755Figure 3. Organization of the Hygromycin A Biosynthetic Gene Cluster in S. hygroscopicus NRRL 2388
Each arrow indicates the direction of transcription of each predicted open reading frame. The overlapping cosmid clones namely 2F1, 12G10,
17E3, and 15A10 covering the entire gene cluster is also depicted. The entire putative hygromycin A biosynthetic gene cluster was obtained by
shotgun sequencing 17E3 cosmid and primer walking 7 kb of cosmid 15A10 cosmid clone. The sequence of the entire gene cluster and the
proposed function for individual ORFs is summarized in Table 1, and nucleotide sequence submitted to GenBank with accession number
DQ314862.NDP-L-fucose, was proposed. Genes encoding proteins
with homology to GDP-D-mannose-4,6-dehydratase
(MDH) have been identified in the nystatin, candicidin,
and other antibiotic biosynthetic gene clusters [20–22].
Moreover, the partially reported antibiotic A201A gene
cluster by A. Jimenez and coworker (GenBank accession
number X84374), which bears significant structural sim-
ilarities to hygromycin A (Figure 1), also contains a gene
encoding a putative MDH. A BLAST search for similar
genes in two reported genome sequences from S. coeli-
color A3(2) [23] and S. avermitilis MA-4680 [24] failed to
produce sequences encoding primary metabolic pro-
teins with significant homology. These observations
suggested a gene encoding a putative MDH as a target
for identification of the hygromycin A biosynthetic gene
cluster of S. hygroscopicus.
Accordingly, a pair of degenerate primers based on
the highly conserved motifs observed by creating an
alignment of predicited MDHs was used to amplify a por-
tion of hyg5 from genomic DNA of the hygromycin A pro-
ducer S. hygroscipoicus NRRL 2388. Sequencing con-
firmed that the PCR product encoded a protein with
homology to putative MDH enzymes. The partial hyg5
fragment was then used to screen a cosmid library of
S. hygrocospicus NRRL 2388 to identify hygromycin A
biosynthetic gene cluster. Cosmid clone 2F1 was identi-
fied through screening the first 600 cosmid clones and
was sequenced. Sequence analysis suggested that
only a portion (15 kb) of the predicted biosynthetic
gene cluster was present. A PCR fragment of hyg14
was obtained with this cosmid clone as a template and
used to further screen the library, resulting in the identi-
fication of three more overlapping cosmid clones,
12G10, 17E3, and 15A10, respectively. The entire puta-
tive hygromycin A biosynthetic gene cluster was ob-
tained by shotgun sequencing 17E3 cosmid and primer
walking 7 kb of cosmid 15A10 (Figure 3).
A contiguous 40 kb DNA region encoding the putative
hygromycin biosynthetic gene cluster was thus se-
quenced adequately on both strands with these three
cosmids (2F1, 17E3, and 15A10) and analyzed for puta-
tive open reading frames (ORFs) with DS Gene software
(Accelrys) and Frame program [25]. A total of 29 ORFs,
designated hyg1–29, were aligned with homologoussequences of GenBank by using BLAST programs [26].
The predicted functions of these hyg gene products
and their corresponding homologs are listed in Table
1. Genes adjacent to hyg1 encoded a hypothetical pro-
tein and a putative glucose dehydrogenase, respec-
tively, while those adjacent to hyg29 encoded a putative
pyruvate dehydrogenase and transcriptional regulator.
These genes flanking the 29 hyg ORFs were highly ho-
mologous to genes identified in the genome sequences
of S. coelicolor [23] and S. avermitilis [24], could not
readily be assigned a dedicated function in the biosyn-
thesis of hygromycin A, and likely are involved in other
cellular processes.
Gene Products Putatively Required for 5-Dehydro-a-
L-Fucofuranose Biosynthesis
Analysis of the hyg cluster indicated the presence of
several putative genes believed to be involved in the
proposed biosynthetic pathway to the 5-dehydro-a-L-
fucofuranose moiety from NDP-mannose (Figure 2)
[19]. The hyg5 gene used to identify the biosynthetic
gene cluster encodes a putative MDH that would cata-
lyze the first step in this process, the conversion of an
activated NDP-mannose into NDP-4-keto-6-deoxyman-
nose. The subsequent step was proposed to be a con-
version to NDP-L-fucose (involving epimerization at the
C-3 and C-5 positions of the hexose ring and an
NADPH-dependent reduction at the C-4 position) and
is likely catalyzed by the hyg23 gene product, which
has clear homology (>60% identity) to L-fucose synthe-
tases. The proposed next step, conversion from the py-
ranose to the furanose form, was proposed [19] to fol-
low a similar mechanism to that established for the
UDP-galactopyranomutase [27, 28]. None of the hyg
genes encoded proteins with sequence homology to
this protein and no clear candidate for this step can
be identified. The hyg20 gene product encodes proteins
with homology to transglucosylases in databases and
may catalyze this step. Interestingly, Hyg20 has homol-
ogy to Ata16 protein, which is encoded by the antibiotic
A201A gene cluster. The structure of antibiotic A201A
suggests a pyranose-furanose ring might also be re-
quired in the biosynthetic pathway. The final step in
the predicted pathway to 5-dehydrofucofuranose is an
Chemistry & Biology
756Table 1. Gene Annotation of hyg Gene Cluster and Comparison with Homologous Proteins in the Public Database
Gene Amino Acids Proposed Function Homologous Protein in Database Identity/Similarity Accession Number
hyg1 375 AfsR regulatory protein afsR (S. coelicolor) 37/52 BAA14186
hyg2 399 p-hydroxybenzoate hydroxylase 4-hydroxybenzoate hydroxylase
(B. japonicum)
51/66 NP773060
hyg3 323 Regulatory protein putative regulatory protein
(S. griseus)
42/56 CAA68515
hyg4 173 Chorismate lyase Chorismate pyruvate lyase
(Methanopyrus kandleri)
28/44 NP613406
hyg5 352 Mannose dehydratase GDP-D-mannose dehydratase
(Kineococcus radiotolerans)
67/77 ZP00227152
hyg6 249 Methyltransferase Ata11 protein (Saccharothrix
mutabilis subsp. capreolus)
31/42 CAD62205
hyg7 579 Unknown hypothetical protein (M. avium) 51/67 NP963248
hyg8 411 Aminotransferase aminotransferase
(Prochlorococcus marinus)
33/52 NP893936
hyg9 83 ACP AtaPKS2 protein (Saccharothrix
mutabilis subsp. capreolus)
34/55 CAD62191
hyg10 378 b-ketoacyl synthase 1 AtaPKS3 protein (Saccharothrix
mutabilis subsp. capreolus)
54/64 CAD62192
hyg11 252 Unknown Ata9PKS4 protein (Saccharothrix
mutabilis subsp. capreolus)
48/59 CAD62193
hyg12 451 CoA-ligase Ata18 protein (Saccharothrix
mutabilis subsp. capreolus)
48/61 CAD62194
hyg13 96 ACP Ata19 protein (Saccharothrix
mutabilis subsp. capreolus)
43/64 CAD62195
hyg14 347 3-hydroxyacyl ACP dehydratase Ata2 protein (Saccharothrix
mutabilis subsp. capreolus)
43/59 CAD62196
hyg15 256 3-ketoacyl ACP reductase Ata4 protein (Saccharothrix
mutabilis subsp. capreolus)
54/67 CAD62198
hyg16 431 Glycosyltranferase Ata5 protein (Saccharothrix
mutabilis subsp. capreolus)
63/74 CAD62199
hyg17 330 myo-inositol dehydrogenase hypothetical protein (M. avium) 41/56 NP962413
hyg18 363 myo-inositol-1-phosphate
synthase
Myo-inositol-1-phosphate
synthase (Thermobifida fusca)
78/87 ZP00291606
hyg19 416 Transmembrane protein Ata9 protein (Saccharothrix
mutabilis subsp. capreolus)
50/63 CAD62203
hyg20 370 Transglucosylase Ata16 protein (Saccharothrix
mutabilis subsp. capreolus)
60/71 CAD62189
hyg21 183 Phosphotranseferase Ard2 protein (Saccharothrix
mutabilis subsp. capreolus)
56/66 CAD62197
hyg22 391 Acyltransferase AtaPKS1 protein (Saccharothrix
mutabilis subsp. capreolus)
45/52 CAD27643
hyg23 325 Fucose synthase EpiA (M. avium) 62/74 NP960166
hyg24 287 Unknown hypothetical protein (M. avium) 43/58 NP962413
hyg25 213 myo-inositol-1-phosphatase stsD (S. griseus) 44/59 CAA70013
hyg26 271 Short chain dehydrogenase hypothetical protein (M. avium) 53/70 NP961344
hyg27 401 DAHPS synthase DAHP synthase (Actinosynnema
pretiosum)
62/71 AAC13561
hyg28 570 ABC transporter Putative ABC transporter
(S. avermitilis)
78/86 NP822846
hyg29 378 Methyltransferase carboxylmethyltransferase
(Thermobifida fusca)
45/59 ZP00293268oxidation and is assigned to the hyg26 gene product
that has homology to a family of short-chain dehydroge-
nases (Table 1). As described below, subsequent ge-
netic experiments have confirmed this assignment. A
glycosyltransferase encoded by hyg16 is expected to
be responsible for formation of the glycosidic linkage
between the 5-dihydro-a-L-fucofuranose and the 4-hy-
droxy group of the (E)-3-(3,4-dihydroxyphenyl)-2-methyl-
acrylic acid moiety (the juncture in the biosynthetic
process in which this link is formed has yet to be deter-
mined). A similar glycosidic linkage is required in the
biosynthesis of antibiotic A201A and may be carried
out by the Ata5 protein, which has 63% identity to the
Hyg16 (Table 1).Gene Products Putatively Required for
(E)-3-(3,4-Dihydroxyphenyl)-2-Methylacrylic
Acid Biosynthesis
Based on the results from previous biosynthetic studies
with 13C labeled precursors, we had proposed that this
central (E)-3-(3,4-dihydroxyphenyl)-2-methylacrylic
acid moiety was derived from a condensation of methyl-
malonyl-ACP with 3,4-dihydroxybenzoyl CoA or 4-hy-
droxybenzoyl CoA [19]. The 3-keto group of the resulting
3-(3,4 dihydroxyphenyl)-3-oxopropanoyl CoA (ACP)
would then be processed by reduction and dehydration
steps in a manner similar to that observed for polyketide
biosynthetic processes (Figure 2). The gene products of
hyg9–15, hyg27, hyg4, and hyg22 can be assigned
Hygromycin A Biosynthetic Gene Cluster
757putative roles in this process. As antibiotic A201A has
the same structural moiety as hygromycin A, with the ex-
ception of the 3-hydroxy substituent, similar enzymes
are anticipated to be required for their biosynthesis. At
the time this project was initiated, a partial sequence
of the antibiotic A201A gene sequence had been re-
ported. Analysis showed that ard1 and ard2 were resis-
tance determinants, while ataP3, ataP5, ataP4, and
ataP7 were likely involved in formation of the N6,N6-di-
methyl-30-amino-30-deoxyadenosine moiety, which is
not present in hygromycin A (the full sequence of the
ataPKS1 gene was also reported). Additional sequence
information from this cluster has now been deposited
and is consistent with our prediction; clear homologs
of hyg9–15 and hyg22 are observed (Table 1).
The pathway to this moiety is proposed to start with 4-
hydroxybenzoic acid, derived from chorismate via the
enzyme chorismate lyase. A putative chorismate lyase
is encoded by hyg4 (Table 1). The chorismate required
for this enzyme reaction presumably is generated by
the shikimate pathway. The committed step of this path-
way, which generates aromatic amino acids and other
primary metabolites in plants and bacteria [29], is cata-
lyzed by 3-deoxy-D-arabino-heptulosonate 7-phos-
phate (DAHP) synthase. DAHP synthase is subject to
feedback inhibition by aromatic acids by an allosteric
mechanism [30]. Genes encoding homologs of DAHP
synthase are often found in antibiotic biosynthetic
gene clusters where a shikimate metabolite is used as
a biosynthetic precursor. Presumably, these homologs
are not inhibited by aromatic amino acids and help en-
sure an adequate supply of shikimate/chorismate dur-
ing secondary metabolism [31]. Consistent with these
observations, a gene (hyg27) encoding a DAHP syn-
thase homolog is noted in the hygromycin biosynthetic
gene cluster. The hyg2 gene product encodes a protein
with homology to 4-hydroxybenzoate hydroxylase and
is assigned a role in the formation of 3,4-dihydroxyben-
zoic acid. It is not clear if the hydroxylation occurs di-
rectly on 4-hydroxybenzoic acid or at a later juncture
in the biosynthesis of the (E)-3-(3,4-dihydroxyphenyl)-
2-methylacrylic acid moiety. This hydroxylation is not re-
quired in antibiotic A201A biosynthesis, and our analysis
revealed that there is no Hyg2 homolog encoded by the
corresponding biosynthetic gene cluster.
In the following step, the 3,4-dihydroxybenzoic acid
(or 4-hydroxybenzoic acid if the hydroxylation occurs
at a later step in the pathway) is presumably activated
by conversion to a thioester. The hyg12 gene product
is assigned to this step based on its homology to a family
of CoA-ligases (Table 1). This enzyme may catalyze for-
mation of either a coenzyme A or an acyl carrier protein
(ACP) thioester; the predicted sequences of the hyg9
and hyg13 gene products are ACP homologs. One of
these ACPs is presumably required for making methyl-
malonyl ACP for condensation with the activated 3,4-di-
hydroxybenzoyl thioester. The other ACP is also likely
involved in one of the subsequent steps. The sequence
analysis revealed that hyg22 encodes a putative acyl
transferase (AT) with some low sequence similarity to
AT domains in type I modular PKSs and may catalyze
this methylmalonyl CoA-methylmalonyl ACP intercon-
version. The presumed AT ataPKS1 encoded by the an-
tibiotic A201A biosynthetic gene cluster has sequencehomology to both Hyg22 and to AT domains in modular
type I polyketide synthase (PKS) and likely has a similar
role. Sequence analysis of both Hyg21 and the ataPKS1
revealed conserved sequence motifs characteristic of
methylmalonyl-CoA-specific rather than malonyl CoA-
specific ATs [32–34]. In contrast, hyg10 (and the homo-
log from the antibiotic A201A cluster) encodes a b-ke-
toacyl synthase (KS) with low homology to discrete KS
proteins in type II PKS, but not KS domains in modular
type I PKSs. It is presumed that this KS protein, whose
sequence is quite distinct from other known KS pro-
teins, is required for catalyzing the decarboxylative con-
densation reaction with methylmalonyl ACP. A multiple
sequence alignment of the predicted Hyg10 and
AtaPKS3 with the type II PKS KS proteins revealed the
presence of the two highly conserved active site histi-
dines [35], which are presumably required for catalyzing
the methylmalonyl ACP decarboxylation. However, in
both Hyg10 and AtaPKS3, a serine residue is observed
in place of the highly conserved nucleophilic cysteine
residue (required for formation of the acyl thioester inter-
mediate in the catalytic cycle of these enzymes). Al-
though serine acts as the key active site nucleophile in
ATs for generating enzyme bound acyl ester intermedi-
ates [35, 36], we are unaware of such a role for this res-
idue catalyzing C-C bond formation in a b-ketoacyl syn-
thase. A naturally occurring KS domain containing
serine at the active site in place of cysteine has been re-
ported in the loading module of the pimaricin PKS clus-
ter of S. natalensis [37] but most likely catalyzes a decar-
boxylation (C-C bond cleavage) in the same way as KS-
Q domains [38]. The hyg11 gene product exhibited 48%
identity to ataPKS4 of antibiotic A201A gene cluster and
very low amino acid identity to several putative type II
KS proteins in the database. The highly conserved cata-
lytic triad of KS proteins and domains was not observed
in either Hyg11 or A201A, and no clear role can be as-
signed based on the sequence analysis.
The 3-(3,4-dihydrophenyl)-3-hydroxy-2-methyl-pro-
pionyl ACP proposed to be generated by Hyg10 may
be converted to (E)-3-(3,4-dihydroxyphenyl)-2-methyla-
crylyl ACP by the action of a 3-hydroxylacyl ACP dehy-
dratase (Hyg14) and 3-ketoacyl ACP reductase (Hyg15)
(Figure 2). Similar roles can be envisioned for the ata2
and ata4 gene products (with 59% and 67% homology
to Hyg14 and Hyg15, respectively), from antibiotic
A201A gene cluster.
Overall, these analyses reveal the presence of a set of
homologous genes in the both hygromycin A and A201A
gene clusters, which can be assigned to the synthesis of
the (E)-3-(3,4-dihydroxyphenyl)-2-methylacrylic acid
(hygromycin) and (E)-3-(4-hydroxyphenyl)-2-methyla-
crylic acid (antibiotic A201A) moiety. Many aspects of
this proposed process appear unusual, including the
use of a discrete AT to load methylmalonyl CoA and
a KS protein with an active site serine residue. None-
theless, the exact role of these proteins and the speci-
fic ordering of the biosynthetic steps remains to be
determined.
Gene Products Putatively Required for 2L-2-Amino-
2-Deoxy-4,5-O-Methylene-Neo-Inositol Biosynthesis
Previously, we had shown that the aminocyclitol portion
of hygromycin A was derived from glucose and that the
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758incorporation pattern for D-[1,2-13C2]glucose was con-
sistent with a proposed pathway leading from glucose
6-phosphate through a myo-inositol intermediate (Fig-
ure 2). The first two steps of this pathway would require
a myo-inositol-1-phosphate synthase (hyg18 gene
product) and myo-inositol phosphatase (hyg25 gene
product). We have previously noted that these two steps
are also required in the biosynthetic pathway that gener-
ates the scyllo-inosamine-derived moiety of streptomy-
cin moiety. StsD a putative myo-inositol phosphatase in-
volved in the streptomycin biosynthetic pathway has
44% identity to Hyg25 (Table 1). The pathways diverge
after myo-inositol, with a proposed oxidation of C5 in
the case of hygromycin A. A putative inositol dehydroge-
nase (encoded by hyg17) is likely responsible for cata-
lyzing this step. A subsequent transamination catalyzed
by the hyg8 gene product is then proposed to provide
2L-2-amino-2-deoxy-neo-inositol [19]. The Hyg8 se-
quence shows homology to class III pyridoxal-phos-
phate-dependent aminotransferases and low homol-
ogy to L-glutamine:scyllo-inosose aminotransferase
StsC, which catalyzes a similar reaction in streptomycin
biosynthesis [39].
One of the intriguing features of the aminocyclitol por-
tion of hygromycin A is the presence of a C-4 and C-5
methylene bridge. At which stage in the aminocyclitol
biosynthetic process the methylene bridge is formed
remains to be determined. In a previous biosynthetic
study, we have shown labeling of this methylene carbon
of hygromycin by L-[methyl-13C]methionine, consistent
with a pathway utilizing S-adenosylmethionine and
a methyl transferase (hyg6 or hyg29 gene product).
The structure of methoxyhygromycin (Figure 1) sug-
gests that the methyl group may be transferred onto
the C5 hydroxy group and that the penultimate interme-
diate in this pathway would be 2L-2-amino-2-deoxy-5-
O-methyl-neo-inositol (Figure 2). Formation of the final
2L-2-amino-2-deoxy-4,5-O-methylene-neo-inositol would
require an oxidation and represents a highly unusual
conversion in sugar biochemistry. Examination of the
hygromycin biosynthetic gene cluster does not reveal
a clear candidate protein for catalysis of this step. If
formation of the methylene bridge occurs before forma-
tion of the amide bond of hygromycin A, then methoxy-
hygromycin (2), which is reportedly less active than
hygromycin [7] and observed in all fermentations of the
S. hygroscopicus strain, may represent a shunt metabo-
lite. Alternatively, methoxyhygromycin may be the pen-
ultimate intermediate with methylene bridge formation
representing the last step in the biosynthetic pathway.
Resistance Genes
The presence of one or more resistance genes within ac-
tinomycete biosynthetic gene clusters is well docu-
mented [40]. Analysis of the hyg gene cluster revealed
several candidates genes whose predicted products,
a methyltransferase (Hyg6 or Hyg29), a transmembrane
protein (Hyg19), a phosphotransferase (Hyg21), and an
ABC transporter (Hyg28), are likely to be involved in pro-
viding resistance to hygromycin A.
It has been shown that antibacterial activity of hy-
gromycin A involves inhibition of the ribosomal peptidyl
transferase, with a binding site on the large ribosomal
subunit closely related to that observed for chloramphen-icol and lincomycin [4]. We speculate that methylation of
the nucleotide at the binding site of the S. hygroscopicus
ribosome by a methyltransferase would provide resis-
tance to hygromycin A. Ribosomal methylation is a
well-established mechanism of resistance to this class
of antibiotics, and genes encoding the appropriate
methyl transferases are often located within the antibi-
otic biosynthetic gene cluster [41–43].
The hyg21 gene product is predicted to be a phospho-
transferase and has high amino acid sequence similarity
with ard2 gene product from the A201A gene cluster
(66% homology). It has been shown that Ard2 protein
catalyzes an ATP-dependent phosphorylation of the
C2 hydroxyl group in the furanose moiety of antibiotic
A201A, thereby inactivating the aminonucleoside antibi-
otic [44]. Hyg21 may provide resistance to hygromycin A
by a similar mechanism. It has previously been estab-
lished that hygromycin A is a substrate of Acr A/B efflux
pump in E. coli and that this is the major cause for its in-
effectiveness against enteric gram-negative bacteria
such as E. coli and Salmonella where this efflux pump
is widespread [14]. Furthermore, Hyg19 and Hyg28
have amino acid sequence homology to Ata9 (65% sim-
ilarity) and Ard1 (86% similarity), and the ability of Ard1,
a member of the ABC transporter superfamily, to pro-
vide resistance to antibiotic A201A has previously
been established [45]. Therefore, we propose that the
Hyg19 (a transmembrane protein) and Hyg28 (an ABC
transporter) may provide an additional layer of resis-
tance to S. hygroscopicus by catalyzing hygroymcin A
efflux.
Regulatory Genes
Comparison of hyg genes with the databases revealed
two genes that likely regulate hygroymcin A biosynthe-
sis. The hyg1 gene encodes a protein with 52% se-
quence similarity to the AfsR transcriptional regulatory
protein of S. coelicolor A3(2). A clear helix-turn-helix mo-
tif can be identified at the N-terminal region of Hyg1,
which is proposed to be a transcriptional activator for
the pathway. A similar role is envisioned for Hyg3, which
has amino acid sequence homology to the StrR, a path-
way-specific activator that regulates streptomycin bio-
synthetis in S. griseus [46].
Production of 500-Dihydrohygromycin Analogs
A genetic experiment was used to confirm that the hyg
biosynthetic gene cluster is responsible for hygromycin
A biosynthesis. Allelic replacement of the hyg26 gene in
S. hygroscopicus by aac(3)IV resistance marker (confer-
ring apramycin resistance) and oriT led to the SCH30
mutant. As described above, Hyg26 has homology to
a family of short-chain dehydrogenases and is proposed
to catalyze the final oxidative step in the predicted path-
way to 5-dehydrofucofuranose moiety of hygromycin A.
As shown in Figure 4B, HPLC analyses of S. hygro-
scopicus NRRL 2388 reveals the clear presence of hy-
gromycin A (1) and methoxyhygromycin A (2) (the 500 epi-
meric forms of these two compounds appear as smaller
shoulder peaks at a slightly earlier retention time). Pro-
duction levels under the fermentation conditions used
were typically 350 mg/l methoxyhygromycin A and
880 mg/l hygromycin A. In contrast, the SCH30 mutant
generates no detectable levels of hygromycin A or
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(3, 4, and 5 in Figure 4C). The three new fermentation
products were purified and characterized and shown
to be 500-dihydrohygromycin A (3), 500-dihydromethoxy-
hygromycin A (4), and (E)-3-(3-hydroxy-4-O-a-fucofura-
nosylphenyl)-2-methylacrylic acid (5).
500-dihydrohygromycin A (3) was produced in the
SCH30 mutant with fermentation titers of approximately
180 mg/l. MS analyses revealed an m/z of 514 (M + H)+
for 3 (Figure 5B), 2 Da larger than the 512 (M + H)+ ob-
served for hygromycin A and consistent with the pro-
posed structure. Careful LC-MS analyses of the hygrom-
ycin A products from the wild-type strain revealed that 3
may also be produced albeit at low levels (less than 1%
of hygromycin A). A nonstereoselective reduction of hy-
gromycin A with sodium borohydride provided diaste-
reomers of 500-dihydrohygromycin A (peaks 3 and 3a in
Figure 4A). LC-MS analyses revealed an m/z of 514
(M + H)+ for both of these. A coinjection of this diastereo-
meric mixture with 3 isolated from the SCH30 mutant
revealed that it coeluted with peak 3 and not 3a. This ob-
servation is consistent with the proposed structure for
this product and demonstrates that only one diastereo-
meric product is made in this mutant. Proton and 13C
NMR analyses were also consistent with this structure.
A comparative COSY NMR analyses of 3 and hygromy-
cin A revealed the appearance of a new three-proton
doublet (w1.2 ppm) for the C-600 methyl group and a de-
crease in the integration for the peak at w2.1 from six
protons to three protons. This doublet is consistent
with an upfield shift for methyl group at C-600 of 3 due
to the presence of a proton at C-500. The H-500 resonance
appears as a pentet at 3.79 ppm, which couples to the
methyl doublet at w1.2 ppm (H-600) as well as another
peak atw3.6 ppm (H-400). The H-400 resonance (a doublet
in hygromycin A) also changes in 3, where it is now
a doublet of doublets (coupled to both H-500 and H-300)
and is shifted upfield (C-500 is less electron withdrawing).
Figure 4. HPLC Analyses of the Authentic Hygromycin A and Its
Analogs
(A) Overlay of standards generated by reduction and hydrolysis of
pure hygromycin A standard.
(B) Fermentation broth of wild-type strain.
(C) Fermentation broth of the SCH30 mutant. (1, hygromycin A; 2,
methoxyhygromycin A; 3 and 3a, diastereomeric mixture of 500-di-
hydrohygromycin A; 4, 500-dihydromethoxyhygromycin A; 5 and
5a, diastereomeric mixture of (E)-3-(3-hydroxy-4-O-a-fucofuranosyl
phenyl)-2-methylacrylic acid; and 6, hygromycin A aglycone.)The 13C NMR showed the disappearance of the ketone
peak (C-500) at 210.1 ppm and appearance of a new
peak at 69.29 ppm, which corresponds to the new alco-
hol carbon peak (C-500). Small changes in the resonances
of the other furanose carbons were also observed. The
HMQC (heteronuclear multiple quantum coherence)
spectrum analysis was also consistent with structure
of 3. It showed that the new carbon signal at 69.29
ppm (C-500) displays a cross peak at 3.79 ppm (H-500) in
the 1H dimension.
500-dihydromethoxyhygromycin A (4) was produced in
the SCH30 mutant with fermentation titers of approxi-
mately 140 mg/l. MS analyses revealed an m/z of 516
(M + H)+ for 4 (Figure 5B), 4 Da larger than the 512 (M +
H)+ observed for hygromycin A and consistent with the
proposed structure. Careful LC-MS analyses of the hy-
gromycin A products from the wild-type strain revealed
that 4 may also be produced albeit at very low levels
(less than 1% of hygromycin A). Two peaks (each with
an m/z of 516 [M + H]+ by LC-MS analyses), one of which
coelutes with 4, were obtained by a nonstereoselective
reduction of methoxyhygromycin A by using NaBH4.
Proton NMR analyses of the purified 500-dihydromethoxy-
hygromycin A (4) revealed a methoxy singlet at 3.52 ppm,
absent in 3 and hygromycin but present in methoxyhy-
gromycin [7, 11]. The proton resonances for the a-L-
fucofuranose moiety of 4 were the same as those ob-
served for 3, including the presence of an H-500 proton
coupled to both the H-600 methyl protons and H-300 pro-
ton. Analysis of the 13C NMR of dihydromethoxyhygro-
mycin A showed the disappearance of the ketone peak
(C-500) at 210.1 ppm and appearance of a new peak at
69.31 ppm, which corresponds to the new alcohol car-
bon peak (C-500). Small changes in the resonances of
the other furanose carbons were also observed. The
HMQC (heteronuclear multiple quantum coherence)
spectrum analysis was also consistent with structure
of 4, with the new carbon signal at 69.31 ppm (C-500) dis-
playing a cross peak at 3.79 ppm (H-500) in 1H dimension.
Chemical reduction of methoxyhygromycin A with so-
dium borohydride provided a diasteromeric mixture of
dihydromethoxyhygromycin A (4). MS and 1H NMR anal-
ysis were consistent with this being a diastereomeric
mixture of 500-dihydromethoxyhygromycin A (4). This
mixture was coinjected in the HPLC with a sample of
naturally produced dihydromethoxyhygromycin A from
the mutant and one of the peaks of the diasteromeric
mixture coeluted with that of the natural one. The 13C
NMR spectrum of the chemically obtained dihydrome-
thoxyhygromycin A was exactly similar to that obtained
from the mutant, confirming its structure.
The final product isolated from the SCH30 mutant was
(E)-3-(3-hydroxy-4-O-a-fucofuranosylphenyl)-2-methyl-
acrylic acid (5), which was produced at levels of approxi-
mately 125 mg/l. This peak was not observed in fermen-
tations of the wild-type strain. LC-MS revealed an m/z of
363 (M + Na)+ for 5 (Figure 5B), consistent with the pro-
posed structure. Proton and 13C NMR analyses revealed
all of the resonances associated with the a-L-fucofura-
nose and (E)-3-(3,4-dihydroxyphenyl)-2-methylacrylic
acid moieties of both 3 and 4, but not those of the
aminocyclitol moiety, supporting the structural assign-
ment for this compound. Further support was provided
by generating a diastereomeric mixtrure of 5, by
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cin A Analogs from SCH30 Mutant
(A) LC-MS analysis of the fermentation broth
of the SCH30 mutant. Panels in ascending
order represent the total ion chromatogram
and single-ion monitoring for an m/z of 516,
514, and 363.
(B) Mass spectral analyses of hygromycin A
analogs produced by the SCH30 mutant.nonstereoselective reduction of hygromycin A followed
by base hydrolysis. Two products were formed in this
process (5 and 5a in Figure 4A), one of which coeluted
with the purified material obtained from the SCH30
strain.
Acid hydrolysis of a mixture of 3 and 3a, provided the
hygromycin aglycone lacking the furanose moiety (6),
(E)-3-(3,4-dihydroxyphenyl)-2-methyl-N-(2L-2-amino-2-
deoxy-4,5-O-methylene-neo-inositol)acrylamide) (Fig-
ures 1 and 4A). LC-MS analyses failed to show any de-
tectable level of this compound from fermentations of
either the wild-type strain or the SCH30 mutant.
Implication for Hygromycin A Biosynthesis
The analysis of hygromycin products made by strain
SCH30 provides compelling evidence that the last step
in production of the 5-dehydro-a-L-fucofuranose moiety
is an oxidation of a-L-fucofuranose catalyzed by the
hyg26 gene product (Figure 6). It is not possible to deter-
mine from these analyses of the SCH30 mutant if this
oxidation step occurs before or after formation of the
glycosidic bond with the (E)-3-(3,4-dihydroxyphenyl)-2-methylacrylic acid moiety of hygromycin A. Nonethe-
less, studies in which either 3 or 4 was fed to a hyg23
mutant (this mutant is presumably blocked in formation
of the L-fucose and does not produce any detectable
hygromycin products) (N.P., S.A., and K.A.R., unpub-
lished data) does not lead to hygromycin production.
This suggests that both 3 and 4 are shunt products,
and not pathway intermediates. While not conclusive,
this observation suggests that the Hyg26 catalyzed oxi-
dation may occur at an earlier stage in the biosynthetic
process (Figure 6).
The production of significant levels of 5 in the SCH30
mutant suggests that the glycosidic linkage in hygromy-
cin A can be formed in the absence of the amide linkage.
In fermentations of the wild-type strain, the SCH 30, and
the hyg23 mutant (blocked in formation of NDP-acti-
vated L-fucose), a hygromycin A analog lacking the de-
hydrofucofuranose moiety (6) was not observed. These
observations suggest that the glycosidic bond of hy-
gromycin may both precede and be a prerequisite for
formation of the amide linkage (Figure 6). It is not possi-
ble to determine from these analyses if there is a specific
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Hygromycin A Biosynthesis and Role of the
hyg26 Gene Productstep in the conversion of 4-hydroxybenzoic acid to the
(E)-3-(3,4-dihydroxyphenyl)-2-methylacrylyl thioester
where this glycosidic bond is formed.
The combined yields of 3 and 4 in the SCH30 (320 mg/
l) are approximately 25% of levels of 1 and 2 produced
by the wild-type strain, suggesting that the enzymes
catalyzing the amide and/or glycosidic bond formation
have some degree of substrate flexibility. Nonetheless,
the significant yields of 5 indicate that amide bond for-
mation is perhaps slower by using a pathway intermedi-
ate with a fucofuranose moiety, possibly leading to for-
mation of this shunt metabolite through a hydrolytic
process.
Significance
This work describes a new and unusual biosynthetic
gene cluster that makes hygromycin A and methoxy-
hygromycin A, which are structurally unusual amino-
cyclitol antibiotics produced by Streptomyces hygro-
scopicus NRRL 2388. This is the first reported gene
cluster for a member of this class of important com-
pounds. Among the notable features of the hygromy-
cin A biosynthesis is the convergent nature of the pro-
cess and the ability to generate a highly unusual
aminocyclitol moiety with a methylene bridge that is
essential for biological activity. We have established
a genetic system formanipulating the hygromycin bio-
synthetic gene cluster in S. hygroscopicus and have
shown that this can be used to provide significant
yields of new hygromycin A analogs in a stereoselec-
tive and cost-effective manner. Hygromycin A analogs
may serve as useful starting points for producing mol-
ecules with potential clinical or agricultural applica-
tions.
Experimental Procedures
Bacterial Strains, Media, and Culture Conditions
S. hygroscopicus NRRL 2388 and the SCH30 mutant were main-
tained and grown on ISP2 medium (0.4% yeast extract, 1.0% malt
extract, 0.4% dextrose, 2.0% agar at pH 7.2), while the mannitolsoy flour (MS) media [47] was used for intergeneric conjugation.
All E. coli strains in this study were grown following standard
protocols [48].
PCR Amplification of a Partial GDP-D-Mannose
4,6-Dehydratase Gene
Amplification of a partial hyg5 gene encoding a putative MDH from S.
hygroscopicus NRRL 2388 was achieved with a set of degenerate
primers: Myco-F1, AARCGHGCRCTGATCACYGGA; and Myco-R1,
CGSGGBGATTCGTGRTTGAA. These primers were designed based
on highly conserved motifs identified by creating a multiple align-
ment of deposited putative MDH genes of pimJ (CAC20923), nysDIII
(AAF71765), amphDIII (AAK73500), and ata12 (CAD27644). Using
a GC-rich PCR kit (Roche, Indianapolis, IN) with these primers and
genomic DNA of S. hygroscopicus NRRL 2388, we amplified
a PCR product of the expected size (w500–600 bp). This fragment
was cloned and sequenced, and a BLAST search revealed the pre-
dicted product had greater than 78% amino acid sequence similarity
to other putative MDHs. This partial hyg5 gene was used as probe to
screen a cosmid clone genomic library of S. hygroscopicus NRRL
2388 and led to the identification of the hygromycin A biosynthetic
gene cluster.
Cloning, Sequencing, and Annotation of the Hygromycin A
Biosynthetic Gene Cluster
The total genomic DNA of S. hygroscopicus NRRL 2388 was pre-
pared following standard protocols [47]. A genomic library was con-
structed by using Supercos-1 cosmid vector as recommended in the
manufacturer’s protocol (Stratagene, La Jolla, CA). Approximately
3000 cosmid clones were probed with the DNA of a digoxigenin-
labeled partial hyg5. Preparation of the digoxigenin probes and
the subsequent hybridization and detection were performed as rec-
ommended in the manufacturer’s protocol (Roche). The overlapping
cosmid clones identified by the hyg5 probe were sequenced to com-
pletion with the TOPO shotgun subcloning kit (Invitrogen, Carlsbad,
CA). Automated DNA sequencing was performed on an ABI Prism
3700 DNA sequencer at DNA core facility of Medical College of Vir-
ginia, Virginia Commonwealth University. The DNA sequences
were assembled with SeqMan II (DNASTAR, Inc., Madison, WI).
The assembled DNA and deduced protein sequences were analyzed
with DS Gene software (Accelrys, San Diego, CA) and Frame pro-
gram [25] and compared with sequences in the public databases
with the BLAST suite of programs [26].
Allelic Replacement of hyg26 within the Hygromycin A
Biosynthetic Gene Cluster
The hyg26 gene of the hygromycin A biosynthetic gene cluster was
replaced with aac(3)IV by the PCR-targeted Streptomyces gene
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762replacement method [49]. The aac(3)IV resistance marker (confer-
ring apramycin resistance) and oriT were amplified from the
pIJ773 disruption cassette with the primers [49]. The primers were
HYG26-F 50- GTCACATCCTTGATCGTTGCGGAAAGGGCATGGGC
GATGATTCCGGGGA-TCCGTCGACC-30 and HYG26-R 50-CGTCG
GCGAGCGGCTGACCGCGGACGGTT-GCGCGGCTCATGTAGGCT
GGAGCTGCTTC-30 (sequence homologous to pIJ773 disruption
cassette is shown in bold, italicized text). The resulting PCR product
from this set of primers was used to replace hyg26 first in the cosmid
clone 17E3 and then in S. hygroscopicus NRRL 2388 to generate the
SCH30 mutant (Dhyg26: aac(3)IV) by the intergeneric conjugation
method [49]. Allelic replacement of the hyg26 gene in SCH30 mutant
was confirmed by PCR amplification and sequencing.
Production and Analysis of Hygromycin A
S. hygroscopicus NRRL 2388 and the SCH30 mutant were cultivated
as reported previously [19]. Mycelia were removed by centrifuga-
tion, and the resulting supernatant was analyzed directly by HPLC.
HPLC and LC-MS Analyses
The culture filtrates of wild-type and mutant strain were subjected to
HPLC and LC-MS analyses with a 5 mm Discovery HS C18 reverse
phase column (4.63 250 mm, Supelco, Belefonte, PA) and a metha-
nol:water (containing 0.05% formic acid) gradient from 10:90 to
90:10 over 40 min at 1.0 ml/min flow rate. Hygromycin A and related
compounds were detected at 272 nm and by MS analyses with a
Perkin-Elmer SCIEX API 2000 pneumatically assisted electrospray
triple quadrapole mass spectrometer.
Purification and Characterization of Hygromycin A Analogs
Produced by the S. Hygroscopicus SCH30 Mutant
Three hygromycin A related products observed in the culture filtrate
of the SCH30 mutant were purified by semipreparative HPLC with
a C18 reverse-phase column (250 3 10.0 mm, 5 mm, Phenomenex,
Torrance, CA) with the same solvent gradient as for analytical col-
umn and a flow rate of 3 ml/min. The three purified products were
characterized by MS (see above) and NMR analyses. 1H-NMR spec-
tra were obtained on a Varian Inova 400 MHz spectrometer with
a Sun Microsystems Ultra 1 processor and VNMR version 5.1c soft-
ware. 13C-NMR spectra were obtained on an AXZ 400 MHz Brucker
spectrometer.
500-Dihydrohygromycin A (3)
M/z 514 (M + H)+; 1H-NMR (CD3OD, 400MHz) d 7.26 (1H, d, J = 0.8, H-
30), 7.18 (1H, dd, J = 8.4, 1.6, H-90), 6.91 (1H, d, J = 1.6, H-50), 6.86 (1H,
d, J = 8.4, H-80), 5.44 (1H, d, J = 4.4, H-100), 5.24, 4.80 (2H, d, J =
1.2, -OCH2O-), 4.51 (1H, m, H-2), 4.1–4.3 (5H, m, H-2
00, H-300, H-4,
H-5, H-6), 3.97 (1H, t, J = 6.8, H-3), 3.79 (2H, m, H-1, H-500), 3.63
(1H, m, H-400), 2.13 (3H, d, J = 0.8, a-CH3), 1.21 (3H, d, J = 6.4, H-600);
13C-NMR (CD3OD, 100 MHz) d 172.63, 149.08, 146.31, 135.05,
132.95, 132.17, 122.64, 119.07, 118.18, 103.76, 96.23, 87.65, 79.07,
78.22, 75.79, 72.63, 71.54, 71.33, 69.29, 50.26, 19.32, 14.63.
500-Dihydromethoxyhygromycin A (4)
M/z 516 (M + H)+; 1H-NMR (CD3OD, 400MHz) d 7.24 (1H, d, J = 0.8, H-
30), 7.18 (1H, dd, J = 8.4, 1.6, H-90), 6.92 (1H, d, J = 1.6, H-50), 6.87 (1H,
d, J = 8.4, H-80), 5.44 (1H, d, J = 4.4, H-100), 4.63 (1H, t, J = 4.0, H-2),
4.25 (1H, t, J = 8.0, H-300), 4.16 (1H, dd, J = 8.0, 4.4, H-200) 4.0–4.1
(4H, m, H-1, H-3, H-4, H-6), 3.79 (1H, dq, J = 6.4, H-500), 3.74 (1H,
m, H-5), 3.62 (1H, dd, J = 8.0, 6.4, H-400), 3.52 (3H, s, -OCH3), 2.13
(3H, d, J = 0.8, a-CH3), 1.21 (3H, d, J = 6.4, H-6
00); 13C-NMR
(CD3OD, 100 MHz) d 149.10, 146.35, 135.09, 132.96, 132.23,
122.68, 119.10, 118.22, 103.79, 87.68, 79.10, 75.82, 73.27, 69.31,
49.91, 19.34, 14.73.
(E)-3-(3-Hydroxy-4-O-a-Fucofuranosylphenyl)-2-Methylacrylic
Acid (5)
M/z 363 (M + Na)+; 1H-NMR (CD3OD, 400 MHz) d 7.30 (1H, d, J = 0.8,
H-30), 7.18 (1H, dd, J = 8.4, 1.6, H-90), 6.94 (1H, d, J = 1.6, H-50), 6.89
(1H, d, J = 8.4, H-80), 5.45 (1H, d, J = 4.4, H-100), 4.24 (1H, dd, J = 8.4,
7.2, H-300), 4.15 (1H, dd, J = 8.4, 4.4, H-200), 3.79 (1H, dq, J = 6.4, 5.6, H-
500), 3.63 (1H, dd, J = 7.2, 5.6, H-400), 2.08 (3H, d, J = 0.8, a-CH3), 1.20
(3H, d, J = 6.4, H-600); 13C-NMR (CD3OD, 100 MHz) d 149.06, 146.73,
139.98, 132.71, 131.32, 129.70, 123.17, 118.97, 118.44, 103.64, 87.71,
79.11, 75.82, 69.37, 19.31, 14.32.Reduction and Hydrolysis of Hygromycin A
1.15 g (2.25 mmol) of hygromycin A was dissolved in water (8.5 ml)
and cooled to 0C. The solution was treated with NaBH4 (85 mg,
2.25 mmol, one equiv.) dissolved in water (1.5 ml). The reaction
was allowed to warm to room temperature, and the disappearance
of hygromycin A (complete within 3 hr) was monitored by HPLC. A
portion (2.5 ml) of the diastereomeric mixture of products (1:1 mix-
ture of 500-epimers) was purified by the semipreparative HPLC con-
ditions described above. MS and 1H NMR analysis were consistent
with this being a diastereomeric mixture of 500-dihydrohygromycin A
(3). Another portion (2.5 ml) of this diastereomeric mixture of 3 was
treated with 1.5 ml aqueous NaOH solution, to give a final NaOH con-
centration of 6 M, under reflux conditions for 6 hr. HPLC analysis re-
vealed that the two peaks for the 500 diastereomers of 3 were lost.
Two new peaks were observed, and these were purified by semipre-
parative HPLC, and MS and 1H NMR analyses were consistent with
a diastereomeric mixture of (E)-3-(3-hydroxy-4-O-a-fucofuranosyl-
phenyl)-2-methylacrylic acid (5). The final portion (5 ml) of the re-
maining diastereomeric mixture of 3 was cooled to 0C, treated
with 0.3 ml concentrated HCl, and stirred overnight at 50C. The hy-
gromycin A aglycone (6, (E)-3-(3,4-dihydroxyphenyl)-2-methyl-N-
(2L-2-amino-2-deoxy-4,5-O-methylene-neo inositol acrylamide)
(Figure 1) was precipitated by cooling the reaction mixture to 0C
and subsequently filtering and rinsing with cold acetone. LC-MS
analysis of the product was a single peak with the predicted molec-
ular mass (m/z 368 [M + H]+).
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